Gingko bioworks stock.
14.93%. Trailing 12-Months. The Ginkgo Bioworks Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does ...
Ginkgo Bioworks (NYSE: DNA) stock is rising higher on Wednesday after the company won a contract from the Defense Advanced Research Projects Agency (DARPA). This contract is worth $18 million over ...Detailed statistics for Ginkgo Bioworks Holdings, Inc. (DNA) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Ginkgo Bioworks Holdings, Inc. ... Ginkgo Bioworks Holdings, Inc. (DNA) NYSE: DNA · IEX Real-Time Price · USD. Add to Watchlist 1.46 +0.08 (5.80%)DNA New York Stock Exchange • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. GINKGO BIOWORKS HOLDINGS, INC. (DNA) Compare. GINKGO BIOWORKS HOLDINGS, ...Feb 22, 2023 · Ginkgo Bioworks delivers some encouraging results. In January, Ginkgo released preliminary numbers for the full-year 2022 that indicated strong growth. The company expects its total revenue to ...
How Could You Make A Quick Recovery From Ginkgo Bioworks Holdings Inc (NYSE: DNA) Given A -400.0% Drop From Highs? Marketing Sentinel about 4 hours ago Facing Competition, But Still Strong: Ginkgo Bioworks Holdings Inc (NYSE:DNA) Is in red zone with the indicator reading -3.47% Stock Equity about 12 hours ago 3 Synthetic Biology …Ark Invest has purchased Ginkgo Bioworks (NYSE: DNA) six times this month. Shares of Ginkgo Bioworks (NYSE: DNA) have had a disastrous 2022, with the company losing over 65% of its market ...Ark Invest has purchased more than 3.5 million shares of Ginkgo Bioworks since June 29.; The biotech company is now the fund’s 23rd largest holding. Shares of DNA stock are down over 65% year-to ...
Ginkgo Bioworks Holdings Inc stock has a Growth Score of 24, Estimate Revisions Score of 29 and Quality Score of 13. Comparing Ideaya Biosciences Inc and Ginkgo Bioworks Holdings Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your …Ginkgo Bioworks Holdings Inc DNA Morningstar Rating Stock XNYS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …
Pfizer Is Sending Ginkgo Bioworks (DNA) Stock Higher: Here's Why benzinga.com - September 27 at 7:18 PM: Why Ginkgo Bioworks Stock Is Surging Higher Today msn.com - September 27 at 2:17 PM: Ginkgo Bioworks and the Government of the Republic of Madagascar Announce Plans to Develop New Biosecurity Capabilities …Find out the direct holders, institutional holders and mutual fund holders for Ginkgo Bioworks Holdings, Inc. (DNA). This week has proven to be a rough one for investors in Ginkgo Bioworks (NYSE:DNA) stock.After announcing a $100 million public offering, DNA stock has lost more than 20% of its value in the past ...A high-level overview of Ginkgo Bioworks Holdings, Inc. (DNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Interactive Chart for Ginkgo Bioworks Holdings, Inc. (DNA), analyze all the data with a huge range of indicators.
Boston-based Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, becoming the latest company to close a SPAC merger and go public. Shares opened at $11.15 apiece under ticker ...
Ginkgo Bioworks banner on the façade of the New York Stock Exchange building. Ginkgo Bioworks . Ginkgo Bioworks is getting ready for another year of disrupting the entire biotech industry model ...Share price volatility. Over the last 12 months, Ginkgo Bioworks's shares have ranged in value from as little as $1.12 up to $2.86. A popular way to gauge a stock's volatility is its "beta". DNA.US volatility (beta: 1.32) Avg. volatility (beta: 1.00) Low High. Beta is a measure of a share's volatility in relation to the market.Current stock price of Ginkgo Bioworks Inc. (DNA) online. Stock quotes and charts for Ginkgo Bioworks Inc. (DNA) on the website of Just2Trade broker.9 de nov. de 2023 ... Instrument Name Ginkgo Bioworks Hldgs Inc Instrument Symbol (DNA-N). Instrument Exchange NYSE. Add to Watchlist ...Feb 22, 2023 · Ginkgo Bioworks delivers some encouraging results. In January, Ginkgo released preliminary numbers for the full-year 2022 that indicated strong growth. The company expects its total revenue to ...
DNA Stock Forecast: Welcome to our series of Stock Forecasts, Predictions and Price Targets for 2023, 2024, 2025, 2030.Today we will analyse stocks from both technical and fundamental analysis and today’s stock is- DNA, DNA Stock Forecast 2023, 2024, 2025, 2030, 2040, 2050.Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry ...Ginkgo Bioworks Holdings Inc - Class A (NYSE:DNA) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions.Ginkgo Bioworks. Market Cap. $3B. Today's Change. (1.59%) $0.02. Current Price. $1.28. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing ...On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal. On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. This week was one to forget for Ginkgo Bioworks ( DNA 5.80%) shareholders. In the Monday-to-Friday period, their investment lost slightly more than 8% of its value on the stock market, according ...
8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.
Shares of Ginkgo Bioworks ( DNA 5.80%) were jumping 18.2% higher as of 10:58 a.m. ET. The nice gain came after the company announced its 2021 fourth-quarter and full-year results. Ginkgo reported ...Vivici BV, an innovative B2B ingredients startup company using precision fermentation to make animal-free dairy proteins, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform ...Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $299,400, According to a Recent SEC Filing. MT. Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $112,837, According to a Recent SEC Filing. MT. Summary. Quotes. Charts.Oct 18, 2023 · Ginkgo Bioworks (DNA-7.19%) sells something very original: the large-scale design and production of organisms. And thanks to its innovations, the company has increased revenue almost 800% over the ... According to the issued ratings of 5 analysts in the last year, the consensus rating for Ginkgo Bioworks stock is Hold based on the current 1 sell rating, 3 hold ratings and 1 buy rating for DNA. The average twelve-month price prediction for Ginkgo Bioworks is $3.19 with a high price target of $6.00 and a low price target of $1.25. Learn more ...During the previous two years, 299 institutional investors and hedge funds held shares of Ginkgo Bioworks. The most heavily invested institutionals were General Atlantic L.P. ($927.12M), Senator Investment Group LP ($565.16M), Baillie Gifford & Co. ($432.24M), ARK Investment Management LLC ($329.77M), Vanguard Group Inc. …View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 27, 2023 · Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021. A high-level overview of Ginkgo Bioworks Holdings, Inc. (DNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.
Company profile page for Ginkgo Bioworks Inc including stock price, company news, press releases, executives, board members, and contact information
Ginkgo Bioworks. Cathie Wood's Ark Invest is quickly building a position in a SPAC that plans to merge with Ginkgo Bioworks. The Ark Disruptive Innovation and Genomic Revolution ETFs doubled its ...
All told, these milestones could add up to $144 million for Gingko. Thus, this is potentially good news for the pharmaceutical market and terrific news for Ginkgo Bioworks. In time, all of this ...Ginkgo Bioworks (DNA 10.85%) helps companies produce bio-engineered products that can be game changers in their respective industries. One example includes working with marijuana producer Cronos ...Ginkgo Bioworks Holdings Inc (DNA) share price as of December 1, 2023, is $1.43. If you are investing from India, you can always check the valuation in the INR ...In summary, Ginkgo Bioworks probably isn't the right stock for Warren Buffett. But it could potentially be right for those who are willing to consider a more speculative biotech investment. Either ...Ginkgo Bioworks (DNA-3.47%) helps companies produce bio-engineered products that can be game changers in their respective industries. One example includes working with marijuana producer Cronos ...Ginkgo Bioworks Holdings, Inc. (DNA) delivered earnings and revenue surprises of 11.11% and 30.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for ...Shares of Ginkgo Bioworks ( DNA 5.80%) were jumping 18.2% higher as of 10:58 a.m. ET. The nice gain came after the company announced its 2021 fourth-quarter and full-year results. Ginkgo reported ...For those who are bullish on Ginkgo Bioworks, today's sell-off represents a good buying opportunity. The stock's drop doesn't reflect a fundamental concern that …Ginkgo Bioworks Holdings Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $315.0 million with a -272.3% profit margin. Year-over-year quarterly sales growth most recently was -16.6%.
Vivici BV, an innovative B2B ingredients startup company using precision fermentation to make animal-free dairy proteins, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. Through this collaboration, Vivici will leverage Ginkgo's extensive ...Ark Invest has purchased more than 3.5 million shares of Ginkgo Bioworks since June 29.; The biotech company is now the fund’s 23rd largest holding. Shares of DNA stock are down over 65% year-to ...Dec 1, 2023 · Ginkgo Bioworks Holdings Aktie Profil. Die Ginkgo Bioworks Holdings Aktie wird unter der ISIN US37611X1000 an den Börsen Frankfurt, München, Berlin, New York, NYSE MKT, Bats, NYSE Bsc, Gettex ... Jul 13, 2022 · Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ... Instagram:https://instagram. will medical pay for bracesvideo game stockr y c e yvaluable wuarters 16 de nov. de 2022 ... Ginkgo has granted BTIG, the sole book-running manager for the offering, a 30-day option to purchase up to an additional $15 million shares ...Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next … portfolio monitoring softwaresites to day trade 18 de ago. de 2023 ... Summary · Ginkgo Bioworks' second quarter results were poor, with soft results in both the Cell Engineering and Biosecurity businesses. · The ...Current stock price of Ginkgo Bioworks Inc. (DNA) online. Stock quotes and charts for Ginkgo Bioworks Inc. (DNA) on the website of Just2Trade broker. real estate in tuscany Jul 25, 2022 · Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, ... The all-stock deal values Zymergen at $300 million market capitalization, ... Oct 21, 2023 · The company has gotten a lot of attention from Wall Street, but the jury is out on whether Ginkgo can pull off its vision. One of the most bullish investors in Ginkgo Bioworks is Cathie Wood, the ... Ginkgo has burned over $300 million in cash in each of the past two years, but there was over $1.3 billion on the balance sheet at the end of last year. With large losses and cash burn ongoing ...